These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7032828

  • 41. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N, Knaup G.
    Med Welt; 1983 Feb 04; 34(5):158-61. PubMed ID: 6341756
    [No Abstract] [Full Text] [Related]

  • 42. Hemodynamic and endocrine responses to guanfacine in normotensive volunteers and hypertensive patients.
    Rosenthal JH.
    Am J Cardiol; 1986 Mar 28; 57(9):22E-26E. PubMed ID: 3513526
    [Abstract] [Full Text] [Related]

  • 43. Precipitation by yohimbine of the withdrawal syndromes of clonidine, guanfacine, and methyldopa in the spontaneously hypertensive rat.
    Thoolen MJ, Hendriks JC, Timmermans PB, van Zwieten PA.
    J Cardiovasc Pharmacol; 1983 Mar 28; 5(2):224-8. PubMed ID: 6188894
    [Abstract] [Full Text] [Related]

  • 44. [Antihypertensive effectiveness of a guanfacine/clopamide combination].
    Wetzels E, Weidinger G.
    MMW Munch Med Wochenschr; 1982 Oct 08; 124(40):871-4. PubMed ID: 6815503
    [No Abstract] [Full Text] [Related]

  • 45. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
    Bazika V.
    Cor Vasa; 1987 Oct 08; 29(4 Suppl 1):42-5. PubMed ID: 3315450
    [Abstract] [Full Text] [Related]

  • 46. Long-term treatment of hypertension with guanfacine alone and in combination therapy.
    Seedat YK.
    Br J Clin Pharmacol; 1980 Oct 08; 10 Suppl 1(Suppl 1):65S-66S. PubMed ID: 6994781
    [No Abstract] [Full Text] [Related]

  • 47. A multicenter, randomized, double-blind dose-response evaluation of step-2 guanfacine versus placebo in mild to moderate hypertension.
    Materson BJ, Kessler WB, Alderman MH, Canosa FL, Finnerty FA, Savran SV, McMillen JI, Marlon AM.
    Am J Cardiol; 1986 Mar 28; 57(9):32E-37E. PubMed ID: 3513528
    [Abstract] [Full Text] [Related]

  • 48. Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension.
    Collart F, Staroukine M, Verniory A.
    Acta Cardiol; 1985 Mar 28; 40(3):269-76. PubMed ID: 3895792
    [Abstract] [Full Text] [Related]

  • 49. Examination of the antihypertensive action of long-term estulic (Egis-Sandoz) treatment.
    Zeher M, Antal L, Azad AQ, Szegedi G.
    Ther Hung; 1988 Mar 28; 36(3):103-8. PubMed ID: 3074520
    [No Abstract] [Full Text] [Related]

  • 50. Guanfacine for hypertension.
    Med Lett Drugs Ther; 1987 May 22; 29(740):49-50. PubMed ID: 2883560
    [No Abstract] [Full Text] [Related]

  • 51. Guanfacine as monotherapy for systemic hypertension.
    Fillingim JM, Blackshear JL, Strauss A, Strauss M.
    Am J Cardiol; 1986 Mar 28; 57(9):50E-54E. PubMed ID: 3513531
    [Abstract] [Full Text] [Related]

  • 52. Long-term clinical experience with guanfacine.
    Fetkovská N, Brimichová G, Sebeková K, Dzúrik R.
    Cor Vasa; 1987 Mar 28; 29(4 Suppl 1):23-9. PubMed ID: 3315447
    [Abstract] [Full Text] [Related]

  • 53. Effects of abrupt cessation of treatment with clonidine and guanfacine on blood pressure and heart rate in spontaneously hypertensive rats.
    Koike Y, Togashi H, Shimamura K, Yomaida I, Saito H.
    Clin Exp Hypertens (1978); 1981 Mar 28; 3(1):103-20. PubMed ID: 7009101
    [Abstract] [Full Text] [Related]

  • 54. Antihypertensive therapy with guanfacine induces elevated plasma growth hormone levels in diabetic patients.
    Coves MJ, Gomis R, Casamitjana R, Lienas V, Vilaradell E.
    J Med; 1989 Mar 28; 20(3-4):291-6. PubMed ID: 2572660
    [Abstract] [Full Text] [Related]

  • 55. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)].
    Rosenthal J, Schäfer N, Rauh J, Raschig A.
    Dtsch Med Wochenschr; 1980 Nov 28; 105(48):1680-4. PubMed ID: 7002524
    [Abstract] [Full Text] [Related]

  • 56. A new centrally action antihypertensive agent guanfacine (BS 100-141).
    Dubach UC, Huwyler R, Radielovic P, Singeisen M.
    Arzneimittelforschung; 1977 Nov 28; 27(3):674-6. PubMed ID: 326262
    [Abstract] [Full Text] [Related]

  • 57. Guanfacine in the treatment of hypertension due to pre-eclamptic toxaemia in thirty women.
    Philipp E.
    Br J Clin Pharmacol; 1980 Nov 28; 10 Suppl 1(Suppl 1):137S-140S. PubMed ID: 6994768
    [Abstract] [Full Text] [Related]

  • 58. [The centrally acting antihypertensive drug guanfacine. Effect on lung function and circulatory parameters in hypertensive patients with bronchial asthma].
    Dorow P, Knaup G.
    ZFA (Stuttgart); 1983 Sep 30; 59(27):1520-4. PubMed ID: 6359750
    [No Abstract] [Full Text] [Related]

  • 59. [Hypotensive and hemodynamic effects of guanfacine in arterial hypertension].
    Erina EV, Beliakova EV, Charyev KhZ, Panfilov VV.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989 Sep 30; 12(1):63-7. PubMed ID: 2663029
    [Abstract] [Full Text] [Related]

  • 60. Effect of guanfacine on ambulatory blood pressure and its variability in elderly patients with essential hypertension.
    Dupont AG, Vanderniepen P, Six RO.
    Br J Clin Pharmacol; 1987 Apr 30; 23(4):397-401. PubMed ID: 3555578
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.